Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UH2/UH3)

Sponsor: National Institutes of Health (multiple Institutes)
Due Date: February 8, 2017
Award: Budget not limited but must reflect actual needs of project. Total duration must not exceed 5 years.